Inst Diagnosti
Instituto de Diagnóstico S.A. provides health services in Chile. It offers patient information and exams instruction, and online services; specialties services; and outpatient services including urgency, laboratory, imaging, vaccination, blood bank, outpatient procedures, and reproductive medicine unit. The company also provides hospitalization services, such as maternity, adult and pediatric hos… Read more
Market Cap & Net Worth: Inst Diagnosti (INDISA)
Inst Diagnosti (SN:INDISA) has a market capitalization of $381.70 Million (CL$383.57 Billion) as of March 18, 2026. Listed on the SN stock exchange, this Chile-based company holds position #12938 globally and #36 in its home market, demonstrating a -0.90% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Inst Diagnosti's stock price CL$2505.60 by its total outstanding shares 153085855 (153.09 Million).
Inst Diagnosti Market Cap History: 2015 to 2026
Inst Diagnosti's market capitalization history from 2015 to 2026. Data shows growth from $209.59 Million to $381.70 Million (5.43% CAGR).
Inst Diagnosti Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Inst Diagnosti's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
Inst Diagnosti's market cap is 0.00 times its annual revenue
0.38x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.03x
Inst Diagnosti's market cap is 0.03 times its annual earnings
6.33x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $209.59 Million | $116.94 Billion | $13.13 Billion | 0.00x | 0.02x |
| 2016 | $275.92 Million | $128.31 Billion | $12.93 Billion | 0.00x | 0.02x |
| 2017 | $315.74 Million | $138.35 Billion | $11.89 Billion | 0.00x | 0.03x |
| 2018 | $301.01 Million | $145.41 Billion | $14.70 Billion | 0.00x | 0.02x |
| 2019 | $236.06 Million | $150.19 Billion | $11.63 Billion | 0.00x | 0.02x |
| 2020 | $209.49 Million | $139.36 Billion | $3.50 Billion | 0.00x | 0.06x |
| 2021 | $225.28 Million | $188.54 Billion | $20.65 Billion | 0.00x | 0.01x |
| 2022 | $240.08 Million | $191.29 Billion | $13.05 Billion | 0.00x | 0.02x |
| 2023 | $192.38 Million | $218.93 Billion | $144.31 Million | 0.00x | 1.33x |
| 2024 | $239.17 Million | $239.07 Billion | $7.28 Billion | 0.00x | 0.03x |
Competitor Companies of INDISA by Market Capitalization
Companies near Inst Diagnosti in the global market cap rankings as of March 18, 2026.
Key companies related to Inst Diagnosti by market ranking:
- HCA Holdings Inc (NYSE:HCA): Ranked #257 globally with a market cap of $79.40 Billion USD.
- Tenet Healthcare Corporation (NYSE:THC): Ranked #1029 globally with a market cap of $18.98 Billion USD.
- Fresenius SE & Co. KGaA (PINK:FSNUF): Ranked #1139 globally with a market cap of $16.86 Billion USD.
- Brookdale Senior Living Inc (NYSE:BKDT): Ranked #1223 globally with a market cap of $15.19 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #257 | HCA Holdings Inc | NYSE:HCA | $79.40 Billion | $525.19 |
| #1029 | Tenet Healthcare Corporation | NYSE:THC | $18.98 Billion | $219.30 |
| #1139 | Fresenius SE & Co. KGaA | PINK:FSNUF | $16.86 Billion | $41.01 |
| #1223 | Brookdale Senior Living Inc | NYSE:BKDT | $15.19 Billion | $77.60 |
Inst Diagnosti Historical Marketcap From 2015 to 2026
Between 2015 and today, Inst Diagnosti's market cap moved from $209.59 Million to $ 381.70 Million, with a yearly change of 5.43%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CL$381.70 Million | -12.70% |
| 2025 | CL$437.22 Million | +82.81% |
| 2024 | CL$239.17 Million | +24.32% |
| 2023 | CL$192.38 Million | -19.87% |
| 2022 | CL$240.08 Million | +6.57% |
| 2021 | CL$225.28 Million | +7.54% |
| 2020 | CL$209.49 Million | -11.26% |
| 2019 | CL$236.06 Million | -21.58% |
| 2018 | CL$301.01 Million | -4.66% |
| 2017 | CL$315.74 Million | +14.43% |
| 2016 | CL$275.92 Million | +31.64% |
| 2015 | CL$209.59 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Inst Diagnosti was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $381.70 Million USD |
| MoneyControl | $381.70 Million USD |
| MarketWatch | $381.70 Million USD |
| marketcap.company | $381.70 Million USD |
| Reuters | $381.70 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.